Price
No data yet.
Social Signal Score
Analyst Ratings
8 analystsRevenue
$32.01M+935.01%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Sean T. Saint
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 422
- Beta
- 3.38
- Country
- US
- Piotroski score
- 2 / 9 (Weak)
- Altman Z-score
- 11.21
Financials
Revenue
$32.01M+935.0%Net Income
$-23.40MEBITDA
$-24.46MFree Cash Flow
$-15.66MEPS (diluted)
$-0.53Shares Outstanding (diluted)
44.55M+3.9%Operating Expenses
$44.48MCash & Debt
$180.49MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $100.25M | $-73.20M | $-1.81 |
| 2024 | $65.12M | $-54.76M | $-1.28 |
| 2023 | $11.99M | $-44.10M | $-1.03 |
| 2022 | $179.0K | $-64.75M | $-1.51 |
Valuation
BBNXhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
50+0.00%Social Signal Score
Mentions (16)
- Newsgurufocus.com·20h ago·Neutral
Beta Bionics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - BBNX Beta Bionics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - BBNXPR NewswireNEW YORK, Oct. 20, 2026NEW YORK, Oct.
View source ↗ - Newszacks.com·22d ago·Neutral
Beta Bionics Stock Down Despite iLet-Eversense 365 Integration Deal BBNX's Eversense 365 partnership is likely to broaden CGM choice and strengthen its automated insulin delivery ecosystem across iLet and mint.
View source ↗ - Newsglobenewswire.com·22d ago·Neutral
Beta Bionics to Announce Third Quarter 2026 Financial Results on October 27, 2026 IRVINE, Calif., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its third quarter 2026 financial results after the financial markets close on Tuesday, October 27, 2026.
View source ↗ - Newsgurufocus.com·27d ago·Negative
BBNX Investors Have Opportunity to Lead Beta Bionics, Inc. Securities Fraud Lawsuit BBNX Investors Have Opportunity to Lead Beta Bionics, Inc. Securities Fraud LawsuitPR NewswireNew York, Sept. 23, 2026New York, Sept. 23, 2026 /PRNewswire/ --
View source ↗ - Newsglobenewswire.com·28d ago·Negative
$BBNX Stock Notification: Beta Bionics has been Sued for Securities Fraud after Medical Device Safety Issues Disclosed – Investors are Alerted to Contact BFA Law by November 3 Beta Bionics has been Sued for Securities Fraud after Medical Device Safety Issues Disclosed – Investors are Alerted to Contact BFA Law by November 3
View source ↗ - Newsglobenewswire.com·34d ago·Negative
Beta Bionics Announces Closing of $172.5 Million Public Offering of Common Stock IRVINE, Calif., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX) today announced the closing of its previously announced underwritten public offering of 7,652,175 shares of its common stock at a price to the public of $17.25 per share and, in lieu of shares of common stock to certain investors, pre-funded warrants to purchase 1,043,484 shares of common stock at a purchase price of $17.2499 per sh…
View source ↗ - Newszacks.com·34d ago·Neutral
Beta Bionics Stock Surges on FDA Clearance for Mint Patch Pump BBNX's FDA-cleared Mint patch pump expands its diabetes portfolio, with a full U.S. launch planned for the first quarter of 2027.
View source ↗ - Newszacks.com·34d ago·Positive
Beta Bionics, Inc. (BBNX) Surges 15.3%: Is This an Indication of Further Gains? Beta Bionics, Inc. (BBNX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
View source ↗ - Newsbenzinga.com·35d ago·Neutral
Beta Bionics, J.B. Hunt Transport And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session U.S. stock futures were higher this morning, with the Nasdaq 100 futures gaining around 100 points on Wednesday.
View source ↗ - Newsglobenewswire.com·35d ago·Negative
…a Bionics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants IRVINE, Calif., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX) today announced the pricing of an underwritten public offering of 7,652,175 shares of its common stock at a price to the public of $17.25 per share and, in lieu of shares of common stock to certain investors, pre-funded warrants to purchase 1,043,484 shares of common stock at a purchase price of $17.2499 per share, which equal…
View source ↗ - Newsglobenewswire.com·36d ago·Negative
Beta Bionics Announces Proposed Public Offering of $125.0 Million of Common Stock IRVINE, Calif., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX) today announced that it intends to offer and sell, in an underwritten public offering and subject to market and other conditions, $125.0 million of shares of its common stock. All of the shares are being offered by Beta Bionics. In addition, Beta Bionics intends to grant the underwriters for the offering a 30-day option to purchase…
View source ↗ - Newsprnewswire.com·37d ago·Negative
Beta Bionics, Inc. (BBNX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit LOS ANGELES, Sept. 14, 2026 /PRNewswire/ -- The Law Offices of Frank R.
View source ↗ - Newsglobenewswire.com·37d ago·Negative
…tch Pump, and Unveils 3D Intelligence™ as its Next-Generation Insulin Dosing Algorithm IRVINE, Calif., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced U.S. Food and Drug Administration (FDA) clearance of Mint, the Company's patch pump featuring a transformative reusable and disposable architecture that does not require recharging, integrates with industry-leading continuous glu…
View source ↗ - Newsnewsfilecorp.com·40d ago·Positive
Grabar Law Office Investigates Claims on Behalf of Long-term Shareholders of Beta Bionics, Inc. (BBNX) Philadelphia, Pennsylvania--(Newsfile Corp. - September 11, 2026) - Grabar Law Office is investigating claims on behalf of shareholders of Beta Bionics, Inc. (NASDAQ: BBNX). What is This Investigation About?
View source ↗ - Newsbusinesswire.com·42d ago·Negative
BBNX Class Action Notice: Beta Bionics Sued for Securities Fraud After Allegedly Misleading Investors about the Safety of its Medical Device – Investors Urged to Contact BFA Law NEW YORK--(BUSINESS WIRE)---- $BBNX #BBNX--Beta Bionics Sued for Securities Fraud After Allegedly Misleading Investors about the Safety of its Medical Device; Investors Urged to Contact BFA Law.
View source ↗ - Newsbusinesswire.com·45d ago·Neutral
Beta Bionics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – BBNX LOS ANGELES--(BUSINESS WIRE)---- $BBNX--Beta Bionics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – BBNX.
View source ↗
Earnings
Tue, Oct 27(in 5 days)
Consensus estimate $-0.52 per share
Typical surprise +8.8% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Jul 29$-0.53 vs $-0.58beat
- Tue, Apr 21$-0.49 vs $-0.53beat
- Tue, Feb 17$-0.30 vs $-0.42beat
- Tue, Oct 28$-0.33 vs $-0.45beat
- Tue, Jul 29$-0.39 vs $-0.51beat
- Tue, May 6$-0.52 vs $-0.51miss
Estimates and results for BBNX via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by BBNX officers and directors.
- Bought
- —
- Sold
- $5.8m
0 trades
58 trades
- Hopman Marksold
- Hopman Marksold
- Jones Christysold
- Hopman Marksold
- Mensinger Mikesold
- Hopman Marksold
- Hopman Marksold
- Hopman Marksold
42 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in BBNX.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.